Search Results 71-80 of 14109 for SC
Clinical Trials · A Study To Assess Adverse Events And Change In Disease Activity From Intravenous (IV) And Subcutaneous (SC) Lutikizumab In Adult Participants ...
SC nivolumab in-home treatment may be safe, tolerable and/or effective when compared to in-clinic treatment and may reduce the burden of cancer and improve ...
... SC every 3 weeks in patients with advanced or metastatic sarcoma who are refractory to or intolerant to other available therapies. Also, to evaluate safety ...
... South Carolina home. He completed undergrad as well as medical school at the University of South Carolina in Columbia, SC, prior to coming to the Mayo Clinic.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.